Pacific Biosciences of California Inc [NASDAQ: PACB] slipped around 9169998.71 points on Monday, while shares priced at $9170000.0 at the close of the session, down -3.88%. Pacific Biosciences of California Inc stock is now -8.49% down from its year-to-date (YTD) trading value. PACB Stock saw
Pacific Biosciences of California Inc [NASDAQ: PACB] price surged by 6372509 percent to reach at $8889998.81. A sum of 6372509 shares traded at recent session while its average daily volume was at 8.89M shares. Pacific Biosciences of California Inc shares reached a high of $1.215
Pacific Biosciences of California Inc [NASDAQ: PACB] price surged by 15.00 percent to reach at $0.18. The one-year PACB stock forecast points to a potential upside of 31.0. The average equity rating for PACB stock is currently 2.21, trading closer to a bullish pattern in
Pacific Biosciences of California Inc [NASDAQ: PACB] stock went on an upward path that rose over 14.00% on Friday, amounting to a one-week price increase of more than 18.29%. Over the last 12 months, PACB stock dropped by -36.67%. The one-year Pacific Biosciences of California
Pacific Biosciences of California Inc [NASDAQ: PACB] price surged by 6.32 percent to reach at $0.06. The one-year PACB stock forecast points to a potential upside of 45.88. The average equity rating for PACB stock is currently 2.27, trading closer to a bullish pattern in
Pacific Biosciences of California Inc [NASDAQ: PACB] loss -1.26% on the last trading session, reaching $0.91 price per share at the time. If compared to the average trading volume of 8.65M shares, PACB reached a trading volume of 14475451 in the most recent trading day,
Pacific Biosciences of California Inc [NASDAQ: PACB] stock went on a downward path that fall over 0.00% on Tuesday, amounting to a one-week price decrease of less than -11.30%. Over the last 12 months, PACB stock dropped by -53.42%. The one-year Pacific Biosciences of California
Pacific Biosciences of California Inc [NASDAQ: PACB] price plunged by -1.79 percent to reach at -$0.02. The one-year PACB stock forecast points to a potential upside of 45.0. The average equity rating for PACB stock is currently 2.27, trading closer to a bullish pattern in
Pacific Biosciences of California Inc [NASDAQ: PACB] surged by $0.04 during the normal trading session on while it closed the day at $1.13. Pacific Biosciences of California Inc stock has also loss -0.88% of its value over the past 7 days. However, PACB stock has
Pacific Biosciences of California Inc [NASDAQ: PACB] loss -2.56% or -0.03 points to close at $1.14 with a heavy trading volume of 5816422 shares. The daily chart for PACB points out that the company has recorded -44.66% loss over the past six months. If we
Copyright © 2024, Powered by Smart TechOne